When should apixaban (Eliquis) be resumed after transcarotid artery revascularization (TCAR)?

Resuming Apixaban After TCAR

Resume apixaban 48-72 hours after TCAR once adequate hemostasis is established, as TCAR is a high bleeding risk vascular procedure involving carotid stenting.

Bleeding Risk Classification

TCAR should be classified as a high bleeding risk procedure because:

• It involves carotid artery manipulation with stent placement
• Bleeding complications at this site can be catastrophic (airway compromise, stroke)
• Hemodynamic instability occurs in 27.5% of TCAR cases, peaking within the first 3 hours postoperatively 1
• The procedure requires careful blood pressure control to prevent both hemorrhagic transformation and stent thrombosis

Timing of Apixaban Resumption

Based on FDA labeling and guideline consensus, restart apixaban 48-72 hours postoperatively 2:

Standard Approach (Most Patients):

• Wait 48-72 hours after TCAR before resuming full-dose apixaban (5 mg twice daily)
• Ensure adequate hemostasis is established before restarting
• No bridging anticoagulation is needed during this 48-72 hour window 2

High Thromboembolic Risk Patients:

For patients at particularly high risk for thromboembolism (e.g., recent stroke, high CHA₂DS₂-VASc score, mechanical valve):

• Consider reduced-dose apixaban 2.5 mg twice daily starting at 48 hours post-TCAR 3
• Transition to full dose (5 mg twice daily) at 72 hours if hemostasis remains stable
• This staged approach balances stroke prevention against bleeding risk

Key Clinical Considerations

Hemodynamic Monitoring Window

• Critical period: First 3 hours post-TCAR - 23.8% of patients require acute blood pressure/heart rate management during this time 1
• Hemodynamic instability typically resolves by 24 hours (11.3% still requiring intervention)
• Average time to neurologic events is 3.9 hours postoperatively 1
• Do not restart anticoagulation during active hemodynamic instability

Carotid Stenting Context

The 2021 ACC Expert Consensus specifically addresses carotid stenting 4:

• For patients with carotid stenting within 1-3 months who require anticoagulation, continue antiplatelet therapy (clopidogrel preferred) along with the anticoagulant
• After the standard DAPT period (1-3 months post-stenting), antiplatelet therapy may be stopped and patients treated with anticoagulant alone
• For TCAR specifically: Most patients are on aspirin + clopidogrel perioperatively; coordinate with your interventionalist regarding antiplatelet continuation

Symptomatic vs Asymptomatic Lesions

• 35-43% of TCAR patients have symptomatic lesions 5
• Symptomatic patients have higher baseline stroke risk but similar perioperative outcomes with alternative anticoagulation regimens 5
• Timing of resumption should not differ based on symptom status, but rather on bleeding risk and hemostasis

Practical Algorithm

Hour 0-3 Post-TCAR:

• Intensive hemodynamic monitoring
• Hold all anticoagulation
• Assess for bleeding, hematoma, neurologic changes

Hour 3-24 Post-TCAR:

• Continue monitoring
• Assess surgical site for hemostasis
• Hold anticoagulation

Hour 24-48 Post-TCAR:

• If hemostasis secure and no bleeding complications → prepare for anticoagulation resumption
• If ongoing hemodynamic instability or bleeding concerns → continue to hold

Hour 48-72 Post-TCAR:

• Standard risk patients: Resume apixaban 5 mg twice daily
• High thromboembolic risk patients: Consider starting apixaban 2.5 mg twice daily at 48 hours, increase to 5 mg twice daily at 72 hours
• Ensure no hematoma expansion, stable blood pressure, no neurologic changes

Common Pitfalls to Avoid

1. Don't restart too early - The 48-hour minimum is critical given TCAR's high bleeding risk classification 6

2. Don't use bridging anticoagulation - The FDA label explicitly states bridging is not generally required during the 24-48 hour interruption period 2

3. Don't ignore hemodynamic instability - 27.5% of patients require intervention; anticoagulation should be held during active instability 1

4. Don't forget antiplatelet coordination - TCAR patients typically require DAPT for 1-3 months post-stenting; coordinate the full antithrombotic regimen with your vascular surgeon 4

5. Don't apply low-risk surgery timing - Some guidelines suggest 24-hour resumption for low-risk procedures 3, but TCAR does not qualify as low-risk given the consequences of bleeding at the carotid site

The evidence consistently supports waiting 48-72 hours for high bleeding risk procedures, and TCAR clearly falls into this category given its vascular access site, stenting requirements, and documented hemodynamic complications 3, 6, 3, 6, 2.